Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer

9 Feb 2017

Abstract excerpt

BRCA1/BRCA2 germ line (GL) mutation carriers with pancreatic adenocarcinoma (PDAC) may have distinct outcomes. We recently described an apparent more favourable prognosis of surgically resected BRCA-associated PDAC patients in a single-arm, uncontrolled, retrospective study. However, the prognostic impact of GL BRCA1/2 mutations in surgically resected PDAC has not been compared with a matched control population....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Research and Treatments
Share to Pancreatic and Hepatic Oncology Research
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28183138
DOI: 10.1038/bjc.2017.19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerPMID 28183138Read ↗

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.Semantic proximity Read ↗

BRCA1/BRCA2 Germline Mutation Carriers and Sporadic Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

BRCA-mutant pancreatic ductal adenocarcinoma.Semantic proximity Read ↗

BRCA-Mutated Pancreatic Cancer: From Discovery to Novel Treatment ParadigmsSemantic proximity Read ↗

Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsSemantic proximity Read ↗

Management of BRCA Mutation Carriers With Pancreatic Adenocarcinoma.Semantic proximity Read ↗

Germline mutations in pancreatic cancer and potential new therapeutic optionsSemantic proximity Read ↗

BRCA mutated pancreatic cancer: A change is coming.Semantic proximity Read ↗

Risk of pancreatic ductal adenocarcinoma associated with carriage of BRCA1 and/or BRCA2 mutation: A systematic review and meta-analysis.Semantic proximity Read ↗

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.Semantic proximity Read ↗

Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.